| Goserelin studied in …STUDIED_INderived194 of 194show fewer |
|---|
| → studied in | NCT05827081Phase 3 · recruiting Phase IIIb Study of Ribociclib + ET in Early Breast Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01723774Phase 2 · active not recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer · 194 trials list this drug (39 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287098Phase 2 · recruiting A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer · 194 trials list this drug (39 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05161195Phase 4 · active not recruiting Roll-over Study to Allow Continued Access to Ribociclib · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003752Phase 1/Phase 2 · active not recruiting Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07310420Phase 1 · recruiting A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777263Phase 3 · not yet recruiting ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV) · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115282Phase 3 · active not recruiting Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic · 194 trials list this drug (39 active) | — | — | Breast Carcinoma,Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04484818Phase 3 · active not recruiting Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study · 194 trials list this drug (39 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02476786Phase 2 · recruiting Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942653Phase 2 · active not recruiting Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma · 194 trials list this drug (39 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03671330Phase 2 · completed Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607004Phase 2 · active not recruiting (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07460752Phase 2 · recruiting Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients · 194 trials list this drug (39 active) | — | — | Hormone Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07158021Phase 2 · recruiting Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial · 194 trials list this drug (39 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582499Phase 2 · recruiting Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06953882Phase 2 · recruiting Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860987Phase 2 · completed Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544830Phase 2 · active not recruiting Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361735Phase 2 · active not recruiting Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694819Phase 2 · completed Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) · 194 trials list this drug (39 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06282588Phase 2/Phase 3 · recruiting Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06348134Phase 2 · recruiting Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674140Phase 3 · active not recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04455750Phase 3 · active not recruiting A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 194 trials list this drug (39 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734730Phase 2 · recruiting Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03056755Phase 2 · completed Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023463Phase 1 · active not recruiting Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03822468Phase 2 · completed Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04478266Phase 3 · terminated Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003209Phase 3 · completed Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Hormone Receptor-Positive Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02430480Phase 2 · completed Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05513365Phase 2 · recruiting Phase II Dutasteride in Combination With CAB vs CAB in SDC · 194 trials list this drug (39 active) | — | — | Salivary Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278185Phase 2 · completed Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03936933Phase 3 · terminated Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02430103active not recruiting Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685397Phase 2/Phase 3 · active not recruiting Management of Castration-Resistant Prostate Cancer with Oligometastases · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551495Phase 2 · unknown Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) · 194 trials list this drug (39 active) | — | — | Invasive Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01964170Phase 3 · completed A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839823Phase 2 · completed Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594095Phase 2 · recruiting SNF Platform Study of HR+/ HER2-advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06575257Phase 2 · recruiting Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05163106Phase 2 · completed Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Luminal A Breast Carcinoma,Luminal B Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862143Phase 2 · terminated Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05720260Phase 2 · recruiting Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344472Phase 3 · unknown Detect V / CHEVENDO (Chemo vs. Endo) · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385847Phase 2 · unknown To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272477Phase 2 · completed Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients · 194 trials list this drug (39 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03423199Phase 3 · unknown PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY · 194 trials list this drug (39 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007979Phase 2 · completed Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04536467Phase 2 · unknown Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278120Phase 3 · completed Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02594072NA · unknown Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482807Phase 1 · completed Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541047Phase 3 · completed RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02941926Phase 3 · completed Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01377389Phase 2 · terminated Ipilimumab + Androgen Depravation Therapy in Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002889Phase 2 · completed Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00651326Phase 3 · terminated Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309478Phase 3 · completed Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients · 194 trials list this drug (39 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333370Phase 1 · completed A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771017Phase 2 · withdrawn Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05110170Phase 3 · completed Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05140512Phase 1 · completed Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02058706Phase 2 · completed LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800197unknown Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432172Phase 2 · completed Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03440879NA · terminated Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03447132Phase 3 · completed Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant · 194 trials list this drug (39 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055731Phase 3 · completed Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02914158Phase 3 · unknown Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004124Phase 3 · completed S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04356430Phase 2 · unknown Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02789878Phase 2 · completed Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01989780Phase 2 · completed Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628066Phase 2 · completed Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04894188NA · recruiting Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05212857Phase 2 · unknown Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626507Phase 1 · unknown Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586675Phase 1 · completed TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131893not yet recruiting Neoadjuvant Treatment of Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096847Phase 3 · completed Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01252693Phase 2 · completed International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02907918Phase 2 · terminated Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04563936Phase 3 · completed Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 194 trials list this drug (39 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02917005Phase 2 · unknown PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003653Phase 3 · completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03658213Phase 3 · withdrawn To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04060043early Phase 1 · completed Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104715Phase 3 · completed Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04736108Phase 2 · unknown Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303784Phase 3 · unknown Prostate Adenocarcinoma TransCutaneous Hormones · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059213Phase 2 · completed A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01738724Phase 4 · terminated Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin · 194 trials list this drug (39 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168062Phase 2 · terminated Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742675Phase 2 · unknown Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002633Phase 3 · completed Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068601Phase 3 · completed S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937768Phase 2 · terminated Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186121Phase 2 · completed Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163084Phase 1/Phase 2 · terminated Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03450109Phase 1 · completed A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591549Phase 4 · unknown Fulvestrant in Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165399Phase 2 · completed Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002597Phase 3 · completed Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004635Phase 3 · completed Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423475Phase 3 · completed Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01776008Phase 2 · terminated Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01496131Phase 2 · completed Tecemotide (L-BLP25) in Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120236Phase 2 · completed Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03444025Phase 2 · unknown Neoadjuvant Goserelin for Triple Negative Breast Cancer · 194 trials list this drug (39 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373708Phase 2/Phase 3 · unknown Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02483767Phase 3 · completed Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589472Phase 2 · completed Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712893Phase 3 · completed Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01023061Phase 2 · completed Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02107391Phase 2 · completed Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00170157Phase 2 · completed Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266213Phase 2 · unknown Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002651Phase 3 · completed SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769795Phase 2 · completed Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769548Phase 3 · completed Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01750398Phase 2 · completed Bipolar Androgen-based Therapy for Prostate Cancer (BAT) · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081159Phase 2 · completed Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases · 194 trials list this drug (39 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021450Phase 3 · completed Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00439751Phase 3 · completed Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00429403Phase 3 · terminated Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02749825Phase 4 · terminated Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010010Phase 2 · completed Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01530607Phase 3 · completed Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454571Phase 2 · completed Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00067015Phase 3 · completed Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00108732Phase 2 · completed A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744366Phase 3 · completed One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01242748Phase 3 · terminated A Degarelix Trial in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149356Phase 1 · terminated RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500110Phase 2 · completed Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01368263Phase 2 · terminated Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00631527Phase 1 · completed Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053911Phase 3 · terminated Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02313051Phase 2 · unknown Everolimus trIal for Advanced prememopausaL Breast Cancer Patients · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02132390Phase 3 · unknown Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946920Phase 3 · completed A Trial of Degarelix in Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02072512Phase 2 · unknown The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01250717Phase 2 · completed Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00767286Phase 3 · completed Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884273Phase 3 · completed Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831233Phase 3 · terminated Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002580Phase 3 · completed Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00348998Phase 2 · unknown Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026377Phase 1 · completed SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01240928Phase 1 · withdrawn MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01240941Phase 2 · withdrawn Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002460Phase 3 · unknown Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427245Phase 3 · completed Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002582Phase 3 · completed Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028769Phase 2 · completed S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031850NA · completed Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003394Phase 1/Phase 2 · completed Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012090Phase 2 · completed Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum · 194 trials list this drug (39 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047099Phase 3 · completed Combination Chemotherapy in Treating Women With Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013506Phase 2 · withdrawn Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498901Phase 2 · terminated Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512668Phase 1 · terminated Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer · 194 trials list this drug (39 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217659Phase 2 · withdrawn S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00833248Phase 3 · completed Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014586Phase 3 · terminated Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01205685Phase 2 · terminated Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00605267Phase 3 · completed Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388804Phase 3 · terminated External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00849082Phase 3 · completed Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653757Phase 1/Phase 2 · completed Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00827307NA · completed Zoladex Plus Tamoxifen in Breast Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322348Phase 2 · completed Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888082Phase 3 · withdrawn Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002881Phase 3 · completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00398489Phase 2 · unknown Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00196846Phase 2 · completed Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303524Phase 2 · completed Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00912548Phase 3 · unknown Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255268Phase 4 · withdrawn CMAB vs IMAB in Metastatic Prostate Cancer · 194 trials list this drug (39 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00488722NA · unknown A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer · 194 trials list this drug (39 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293670Phase 4 · unknown FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer · 194 trials list this drug (39 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |